Emotion Regulation and Substance Use Frequency in Women with Substance Dependence and Borderline Personality Disorder Receiving Dialectical Behavior Therapy

Overview

Journal Am J Drug Alcohol Abuse

Publisher Informa Healthcare

Specialty Psychiatry

Date 2010 Nov 25

PMID 21091162

Citations 63

Authors

Seth R Axelrod

Francheska Perepletchikova

Kevin Holtzman

Rajita Sinha

Affiliations

Soon will be listed here.

Abstract

Background: Dialectical behavior therapy (DBT) identifies emotion dysregulation as central to the dangerous impulsivity of borderline personality disorder (BPD) including substance use disorders, and DBT targets improved emotion regulation as a primary mechanism of change. However, improved emotion regulation with DBT and associations between such improvement and behavioral outcomes such as substance use has not been previously reported.

Objective: Thus, the goal of this study was to assess for improvement in emotion regulation and to examine the relationship between improvements in the emotion regulation and substance use problems following DBT treatment.

Method: Emotion regulation as assessed by the Difficulties in Emotion Regulation Scale, depressed mood as assessed by the Beck Depression Inventory, and their associations with substance use frequency were investigated in 27 women with substance dependence and BPD receiving 20 weeks of DBT in an academic community outpatient substance abuse treatment program.

Results: Results indicated improved emotion regulation, improved mood, and decreased substance use frequency. Further, emotion regulation improvement, but not improved mood, explained the variance of decreased substance use frequency.

Conclusion And Scientific Significance: This is the first study to demonstrate improved emotion regulation in BPD patients treated with DBT and to show that improved emotion regulation can account for increased behavioral control in BPD patients. SIGNIFICANCE AND FUTURE RESEARCH: Emotion regulation assessment is recommended for future studies to further clarify the etiology and maintenance of disorders associated with emotional dysregulation such as BPD and substance dependence and to further explore emotion regulation as a potential mechanism of change for clinical interventions.

Citing Articles

Digital Interventions for Symptoms of Borderline Personality Disorder: Systematic Review and Meta-Analysis.

Lindsay J, McGowan N, Henning T, Harriss E, Saunders K J Med Internet Res. 2024; 26:e54941.

PMID: 39612494 PMC: 11645515. DOI: 10.2196/54941.

Early remission of deliberate self-harm predicts emotion regulation capacity in adulthood: 12.4 years follow-up of a randomized controlled trial of adolescents with repeated self-harm and borderline features.

Dibaj I, Tormoen A, Klungsoyr O, Morken K, Haga E, Dymbe K Eur Child Adolesc Psychiatry. 2024; .

PMID: 39470788 DOI: 10.1007/s00787-024-02602-8.

The clinical significance of emotional urgency in bipolar disorder: a scoping review.

Teh W, Si S, Liu J, Subramaniam M, Ho R BMC Psychol. 2024; 12(1):273.

PMID: 38750587 PMC: 11097479. DOI: 10.1186/s40359-024-01700-1.

Longitudinal examination of borderline personality disorder symptoms and drug use: The influence of negative and positive emotion dysregulation.

Waite E, Raudales A, Newberger N, Ferguson J, Denning D, Huffman S Personal Ment Health. 2024; 18(2):157-165.

PMID: 38378990 PMC: 11068492. DOI: 10.1002/pmh.1602.

Emotion differentiation among individuals in a randomized clinical trial for alcohol use disorder: Within- and between-person associations with affect, craving, and alcohol use in daily life.

Knapp K, Bradizza C, Zhao J, Linn B, Wilding G, LaBarre C Behav Res Ther. 2024; 173:104474.

PMID: 38237447 PMC: 10947467. DOI: 10.1016/j.brat.2024.104474.

References

Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

McMain S, Korman L, Dimeff L . Dialectical behavior therapy and the treatment of emotion dysregulation. J Clin Psychol. 2001; 57(2):183-96. DOI: 10.1002/1097-4679(200102)57:2<183::aid-jclp5>3.0.co;2-y. View

Gratz K, Tull M, Baruch D, Bornovalova M, Lejuez C . Factors associated with co-occurring borderline personality disorder among inner-city substance users: the roles of childhood maltreatment, negative affect intensity/reactivity, and emotion dysregulation. Compr Psychiatry. 2008; 49(6):603-15. DOI: 10.1016/j.comppsych.2008.04.005. View

Fox H, Axelrod S, Paliwal P, Sleeper J, Sinha R . Difficulties in emotion regulation and impulse control during cocaine abstinence. Drug Alcohol Depend. 2007; 89(2-3):298-301. DOI: 10.1016/j.drugalcdep.2006.12.026. View

Trull T . Relationships of borderline features to parental mental illness, childhood abuse, Axis I disorder, and current functioning. J Pers Disord. 2001; 15(1):19-32. DOI: 10.1521/pedi.15.1.19.18647. View

Hawkins K, Sinha R . Can line clinicians master the conceptual complexities of dialectical behavior therapy? An evaluation of a State Department of Mental Health training program. J Psychiatr Res. 1998; 32(6):379-84. DOI: 10.1016/s0022-3956(98)00030-2. View

Ross S, Dermatis H, Levounis P, Galanter M . A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. Am J Drug Alcohol Abuse. 2003; 29(2):263-79. DOI: 10.1081/ada-120020511. View

Putnam K, Silk K . Emotion dysregulation and the development of borderline personality disorder. Dev Psychopathol. 2006; 17(4):899-925. DOI: 10.1017/s0954579405050431. View

Kuo J, Linehan M . Disentangling emotion processes in borderline personality disorder: physiological and self-reported assessment of biological vulnerability, baseline intensity, and reactivity to emotionally evocative stimuli. J Abnorm Psychol. 2009; 118(3):531-44. PMC: 4277483. DOI: 10.1037/a0016392. View

10.

Marlowe D, Kirby K, Festinger D, Husband S, Platt J . Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. J Nerv Ment Dis. 1997; 185(8):483-90. DOI: 10.1097/00005053-199708000-00002. View

11.

Russ M, Campbell S, Kakuma T, Harrison K, Zanine E . EEG theta activity and pain insensitivity in self-injurious borderline patients. Psychiatry Res. 2000; 89(3):201-14. DOI: 10.1016/s0165-1781(99)00113-4. View

12.

Woodberry K, Gallo K, Nock M . An experimental pilot study of response to invalidation in young women with features of borderline personality disorder. Psychiatry Res. 2007; 157(1-3):169-80. DOI: 10.1016/j.psychres.2007.06.007. View

13.

Arntz A, Appels C, Sieswerda S . Hypervigilance in borderline disorder: a test with the emotional Stroop paradigm. J Pers Disord. 2001; 14(4):366-73. DOI: 10.1521/pedi.2000.14.4.366. View

14.

van den Bosch L, Verheul R, Schippers G, van den Brink W . Dialectical Behavior Therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav. 2002; 27(6):911-23. DOI: 10.1016/s0306-4603(02)00293-9. View

15.

Linehan M, Comtois K, Murray A, Brown M, Gallop R, Heard H . Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006; 63(7):757-66. DOI: 10.1001/archpsyc.63.7.757. View

16.

Minzenberg M, Fan J, New A, Tang C, Siever L . Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res. 2007; 42(9):727-33. PMC: 2708084. DOI: 10.1016/j.jpsychires.2007.07.015. View

17.

Lenzenweger M, Clarkin J, Fertuck E, Kernberg O . Executive neurocognitive functioning and neurobehavioral systems indicators in borderline personality disorder: a preliminary study. J Pers Disord. 2004; 18(5):421-38. DOI: 10.1521/pedi.18.5.421.51323. View

18.

Kurtz J, Morey L . Negativism in evaluative judgments of words among depressed outpatients with borderline personality disorder. J Pers Disord. 1999; 12(4):351-61. DOI: 10.1521/pedi.1998.12.4.351. View

19.

Sinha R . How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl). 2002; 158(4):343-59. DOI: 10.1007/s002130100917. View

20.

Gratz K, Lacroce D, Gunderson J . Measuring changes in symptoms relevant to borderline personality disorder following short-term treatment across partial hospital and intensive outpatient levels of care. J Psychiatr Pract. 2006; 12(3):153-9. DOI: 10.1097/00131746-200605000-00004. View